Esperion  Therapeutics is an American Public Pharmaceutical company which mainly focuses on the development of Bempedoic Acid. This is a small molecule which is available orally and it is designed to lower the elevated levels of the LDL-C.

This company’s headquarters is located in Ann Arbor, Michigan. The first ever Esp. was founded in 1998 by Dr. Roger Newton, which aims to focus on the licensing and the development of the drugs to modulate the HDL cholesterol.